Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering

Hemab Therapeutics Holdings, Inc., a clinical-stage biotechnology company focused on blood coagulation disorder treatments, priced its initial public offering at $18.00 per share for 16.75 million shares, raising approximately $301.5 million in gross proceeds. The company's stock is expected to begin trading on Nasdaq under ticker symbol 'COAG' on May 1, 2026, with the offering expected to close on May 4, 2026.

04/30/2026, 6:55 PM • GlobeNewswire

Evercore Rides M&A Momentum, Analyst Calls It 'Best Pure-Play Boutique Investment Bank'

BofA Securities initiated coverage of Evercore (NYSE:EVR) with a Buy rating and $435 price target, calling it the 'best pure-play among boutique investment banks.' The analyst highlights Evercore's high advisory revenue mix (80% of total), strong M&A expertise, and growth potential from franchise expansion. With M&A activity expected to reach record highs in 2026, the firm is positioned for positive earnings revisions.

01/26/2026, 11:36 AM • Benzinga

ProQR to Participate in 8th Annual Evercore Healthcare Conference

ProQR Therapeutics will participate in the 8th Annual Evercore Healthcare Conference, presenting its Axiomer™ RNA editing technology platform that enables targeted single nucleotide changes in RNA to potentially develop new disease treatments.

12/01/2025, 8:00 AM • GlobeNewswire

Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences

Madrigal Pharmaceuticals will participate in three upcoming healthcare investor conferences in November and December 2025, presenting live webcasts about their MASH treatment Rezdiffra.

11/17/2025, 8:00 AM • GlobeNewswire

The Stock Market May Do Something Shocking in 2026, According to Wall Street Analysts

Wall Street analysts predict the S&P 500 could experience significant volatility in 2026, with potential scenarios ranging from a 30% surge to a 30% decline, driven by factors like AI adoption, economic conditions, and potential interest rate changes.

10/29/2025, 4:20 AM • The Motley Fool

Standard Lithium Prices Upsized $130 Million Underwritten Public Offering

Standard Lithium announced a public offering of 29,885,057 common shares at $4.35 per share, raising $130 million to fund capital expenditures for its lithium projects in Arkansas and Texas.

10/16/2025, 11:51 PM • GlobeNewswire

3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings

Sprouts Farmers Market stock has fallen 40% since June, but analysts suggest it may be oversold and poised for a potential rebound ahead of upcoming earnings, citing strong historical performance and technical indicators.

10/14/2025, 11:33 AM • Investing

Western Digital Expands SIT Lab For AI Boom

Western Digital has expanded its System Integration and Test (SIT) Lab to a 25,600-square-foot facility, aimed at accelerating customer adoption and addressing growing AI storage demands through high-capacity hard disk drives (HDDs).

10/13/2025, 10:33 AM • Benzinga

Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering

Dianthus Therapeutics plans to raise $150 million through a public offering of common stock or pre-funded warrants, with potential additional $22.5 million from underwriters. Proceeds will support preclinical and clinical development activities.

09/08/2025, 4:00 PM • GlobeNewswire

Amazon Faces Rare Downgrade—Is the Rally at Risk?

Zacks Research downgraded Amazon from Strong Buy to Hold, marking a rare shift in analyst sentiment. Despite the downgrade, most analysts remain bullish, with price targets ranging from $280-$300, and the stock continues to show strong momentum.

09/03/2025, 5:02 AM • Investing

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

Mineralys Therapeutics has priced a public offering of 9,803,921 shares at $25.50 per share, expecting to raise approximately $250 million to fund clinical development and corporate activities.

09/02/2025, 9:33 PM • GlobeNewswire

Why Shares of Centrus Energy Are Soaring Higher This Week

Centrus Energy's stock rose 12.3% after signing a memorandum of understanding with Korea Hydro & Nuclear Power to explore uranium enrichment facility expansion, with Evercore ISI recognizing the company as an emerging player in the U.S. nuclear energy industry.

08/29/2025, 9:13 AM • The Motley Fool

Amazon Stock Sets Up for Breakout After Bullish Crossover

Amazon's stock shows potential for a rally after a bullish MACD crossover, with analysts maintaining a positive outlook and price targets suggesting over 30% upside potential.

08/21/2025, 5:25 PM • Investing

Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors

Ethos, a life insurance technology company, announced the appointment of William J. Wheeler to its Board of Directors. Wheeler brings over three decades of financial services leadership, previously serving as Vice Chairman of Athene Holding and President of MetLife's Americas division.

07/30/2025, 11:00 AM • GlobeNewswire